The Enterprise Value as of December 2024 (TTM) for Anixa Biosciences, Inc. (ANIX) is 82.04M

According to Anixa Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 82.04M. This represents a change of -25.22% compared to the average of 109.70M of the last 4 quarters.

Anixa Biosciences, Inc. (ANIX) Historical Enterprise Value (quarterly & annually)

How has ANIX Enterprise Value performed in the past?

The mean historical Enterprise Value of Anixa Biosciences, Inc. over the last ten years is 70.73M. The current 82.04M Enterprise Value has changed 11.50% with respect to the historical average. Over the past ten years (40 quarters), ANIX's Enterprise Value was at its highest in in the October 2022 quarter at 160.11M. The Enterprise Value was at its lowest in in the July 2017 quarter at 11.67M.

Anixa Biosciences, Inc. (ANIX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anixa Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anixa Biosciences, Inc. (ANIX) Average Enterprise Value

How has ANIX Enterprise Value performed in the past?

The current Enterprise Value of Anixa Biosciences, Inc. (ANIX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Anixa Biosciences, Inc. (ANIX) Enterprise Value vs. Peers

How is ANIX’s Enterprise Value compared to its peers?

Anixa Biosciences, Inc.’s Enterprise Value is greater than Cue Biopharma, Inc. (42.98M), greater than INmune Bio, Inc. (70.25M), greater than IN8bio, Inc. (18.87M), greater than PolyPid Ltd. (30.25M), greater than TFF Pharmaceuticals, Inc. (-2265301.00), less than Immunome, Inc. (531.87M), greater than Annovis Bio, Inc. (48.90M), greater than Aerovate Therapeutics, Inc. (43.34M), greater than Adagene Inc. (8.35M), less than Acrivon Therapeutics, Inc. Common Stock (158.62M), less than Rezolute, Inc. (248.88M), greater than AN2 Therapeutics, Inc. (8.33M), greater than Anebulo Pharmaceuticals, Inc. (31.01M), less than Mineralys Therapeutics, Inc. (502.94M), less than Arcellx, Inc. (4.06B), greater than PMV Pharmaceuticals, Inc. (42.60M), less than Molecular Partners AG (107.67M),

Build a custom stock screener for Anixa Biosciences, Inc. (ANIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anixa Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anixa Biosciences, Inc. (ANIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anixa Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.